Daniel N. Clark

发表

Interferon Alpha in Systemic Lupus Erythematosus

Timothy B. Niewold, T. Niewold, Daniel N. Clark, 2010, Journal of biomedicine & biotechnology.

Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes

Jianming Hu, Ju-Tao Guo, Daniel N. Clark, 2015, Journal of Virology.

Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing

F. B. Johnson, Daniel N. Clark, A. Stewart, 2011, Virology Journal.

The hepatitis B virus polymerase.

J. Tavis, Jianming Hu, Daniel N. Clark, 2021, The Enzymes.

Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target

Daniel N. Clark, Daniel N Clark, Timothy S Buhlig, 2020, Viruses.

Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Jianming Hu, Daniel N. Clark, Daniel N Clark, 2015, Antiviral research.

Unveiling the roles of HBV polymerase for new antiviral strategies.

Jianming Hu, Daniel N. Clark, Daniel N Clark, 2015, Future virology.

In Vitro Assays for RNA Binding and Protein Priming of Hepatitis B Virus Polymerase.

Scott A. Jones, Jianming Hu, Daniel N. Clark, 2017, Methods in molecular biology.

Mapping of Functional Subdomains in the Terminal Protein Domain of Hepatitis B Virus Polymerase

J. Flanagan, Jianming Hu, Daniel N. Clark, 2016, Journal of Virology.

PrimingBinding, RNA Packaging, and Protein Polymerase Sequences Required for Viral Comparative Analysis of Hepatitis B Virus

Scott A. Jones, J. Tavis, Jianming Hu, 2014 .

Comparative Analysis of Hepatitis B Virus Polymerase Sequences Required for Viral RNA Binding, RNA Packaging, and Protein Priming

Scott A. Jones, J. Tavis, Jianming Hu, 2013, Journal of Virology.

Four Promoters of IRF5 Respond Distinctly to Stimuli and are Affected by Autoimmune-Risk Polymorphisms

R. Read, Lissenya B. Argueta, Daniel N. Clark, 2013, Frontiers in Immunology.

Promoter Polymorphisms in Interferon Regulatory Factor 5

Daniel N. Clark, Daniel N Clark, 2013 .

Cytokine inhibition as a strategy for treating systemic lupus erythematosus.

Daniel N. Clark, Brian D. Poole, Daniel N Clark, 2013, Clinical immunology.

Molecular effects of autoimmune-risk promoter polymorphisms on expression, exon choice, and translational efficiency of interferon regulatory factor 5.

Lissenya B. Argueta, Daniel N. Clark, Daniel N Clark, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions

P. Gaffney, J. Harley, J. Guthridge, 2012, Journal of biomedicine & biotechnology.

Interferon and Apoptosis in Systemic Lupus Erythematosus

Daniel N. Clark, Daniel N Clark, B. Poole, 2012 .

The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles

Daniel N. Clark, Daniel N Clark, Madison M Johnson, 2022, Viruses.